ABVC BioPharma, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
ABVC BioPharma, Inc. (ECOC) had Lessee, Operating Lease, Liability, to be Paid, Year One of $442.27 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-12
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $442.27K.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $442.12K.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $441.03K.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $118.60K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $442.27K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $442.12K 10-Q · filed 2026-05-18 |
| 2025-12-31 | $441.03K 10-K · filed 2026-03-03 |
| 2025-09-30 | $118.60K 10-Q/A · filed 2026-03-03 |
| 2025-06-30 | $111.22K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $104.85K 10-Q · filed 2025-04-30 |
| 2024-12-31 | $409.59K 10-K · filed 2025-04-15 |
| 2024-09-30 | $350.09K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $350.62K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $350.81K 10-Q · filed 2024-05-17 |
| 2023-12-31 | $404.75K 10-K · filed 2024-03-13 |
| 2023-09-30 | $96.58K 10-Q · filed 2023-11-15 |
| 2023-06-30 | $194.57K 10-Q · filed 2023-08-14 |